We are live on
!
Find out more
SL
SIB LLC Portfolio holdings
AUM
$190M
1-Year Est. Return
9.27%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+9.27%
3 Year Est. Return
+29.19%
5 Year Est. Return
+154.91%
10 Year Est. Return
+361.81%
AUM
$150M
AUM Growth
-$499K
(-0.33%)
Cap. Flow
-$16.1M
Cap. Flow
% of AUM
-10.76%
Top 10 Holdings %
Top 10 Hldgs %
82.41%
Holding
22
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoodRx Holdings
GDRX
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Old Dominion Freight Line
ODFL
|
+$15.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.74M |
| 3 |
JB Hunt Transport Services
JBHT
|
+$390K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 51.24% |
| 2 | Industrials | 43.01% |
| 3 | Healthcare | 5.73% |
Similar funds
QS
KC
HPFG
LHR
CM
KWM
HFS
CCA
SIB LLC's Q4 2020 Portfolio in Review
As of Q4 2020, SIB LLC held 22 positions worth $150M, down 0.33% from $150M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
SIB LLC withdrew a net $16.1M in Q4 2020, closing 1 position and reducing 2 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $2.74M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 51% of assets, up from 46% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, SIB LLC opened a new position in GoodRx Holdings worth $2.42M.
- SIB LLC's largest Q4 2020 buy was GoodRx Holdings: 60,000 shares worth $2.42M.
- SIB LLC's biggest Q4 2020 reduction was Old Dominion Freight Line, cutting an estimated $15.7M.
- SIB LLC fully exited Bristol-Myers Squibb in Q4 2020, selling an estimated $2.74M.
- SIB LLC's ten largest holdings make up 82% of its $150M portfolio in Q4 2020.
- SIB LLC opened 1 new position and closed 1 in Q4 2020.
- SIB LLC's portfolio value fell 0.33% quarter-over-quarter to $150M.
Based on SIB LLC's 13F filing for Q4 2020, filed 21 Jan 2021.